TY  - GEN
AU  - Coudert,Bruno
AU  - Asselain,Bernard
AU  - Campone,Mario
AU  - Spielmann,Marc
AU  - Machiels,Jean-Pascal
AU  - Pénault-Llorca,Frédérique
AU  - Serin,Daniel
AU  - Lévy,Christelle
AU  - Romieu,Gilles
AU  - Canon,Jean-Luc
AU  - Orfeuvre,Hubert
AU  - Piot,Gilles
AU  - Petit,Thierry
AU  - Jerusalem,Guy
AU  - Audhuy,Bruno
AU  - Veyret,Corinne
AU  - Beauduin,Marc
AU  - Eymard,Jean-Christophe
AU  - Martin,Anne-Laure
AU  - Roché,Henri
TI  - Extended benefit from sequential administration of docetaxel after standard fluorouracil, epirubicin, and cyclophosphamide regimen for node-positive breast cancer: the 8-year follow-up results of the UNICANCER-PACS01 trial
SN  - 1549-490X
PY  - 2013///0207
KW  - Adolescent
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Drug Administration Schedule
KW  - Epirubicin
KW  - Female
KW  - Fluorouracil
KW  - Follow-Up Studies
KW  - Humans
KW  - Lymphatic Metastasis
KW  - Middle Aged
KW  - Survival Rate
KW  - Taxoids
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1634/theoncologist.2011-0442
ER  -